NEW YORK (GenomeWeb News) - Shares in Qiagen slid more than 10 percent to $15.48 in afternoon trading following news that it plans to acquire Digene for $61.50 a share, or around $1.6 billion.
Digene’s shares, meanwhile, were up 27 percent at $56.70 in afternoon trading.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.